- Ticker
- ACET
- Price
- 1.69
- Stock movement down
- -0.09 (-5.06%)
- Company name
- Adicet Bio Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 72.59M
- Ent value
- -146.71M
- Price/Sales
- 2.90
- Price/Book
- 0.25
- Div yield
- 2.37%
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -88.53%
- 3 year return
- -50.58%
- 5 year return
- -54.34%
- 10 year return
- -
Last updated: 2023-09-08
Get the latest news and real-time alerts from Adicet Bio, Inc. (ACET) stock at Seeking Alpha.
August 9, 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adicet Bio, Inc. (ACET) stock at Seeking Alpha.
June 27, 2023
iO Charts is a Seeking Alpha partner
DIVIDENDS
ACET does not pay dividends or no data was received
Loading...
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 2.90 |
| Price to Book | 0.25 |
| EV to Sales | -5.87 |
Get the latest news and real-time alerts from Adicet Bio, Inc. (ACET) stock at Seeking Alpha.
June 27, 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adicet Bio, Inc. (ACET) stock at Seeking Alpha.
June 26, 2023
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 42.95M |
| EPS (TTM) | -2.14 |
| FCF per share (TTM) | -1.89 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 24.99M |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -90.55M |
| Net income (TTM) | -87.71M |
| EPS (TTM) | -2.14 |
| EPS (1y forward) | -1.99 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | -362.35% |
| Profit margin (TTM) | -350.98% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 257.66M |
| Net receivables | 0.00 |
| Total current assets | 261.04M |
| Goodwill | 19.46M |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 330.69M |
| Accounts payable | 4.40M |
| Short/Current long term debt | 21.02M |
| Total current liabilities | 19.71M |
| Total liabilities | 38.35M |
| Shareholder's equity | 292.34M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -55.37M |
| Capital expenditures (TTM) | 22.26M |
| Free cash flow (TTM) | -77.63M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -30.00% |
| Return on Assets | -26.52% |
| Return on Invested Capital | -29.75% |
| Cash Return on Invested Capital | -26.33% |
Loading...
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.79 |
| Daily high | 1.80 |
| Daily low | 1.69 |
| Daily Volume | 273K |
| All-time high | 145.95 |
| 1y analyst estimate | 27.63 |
| Beta | 2.02 |
| EPS (TTM) | -2.14 |
| Dividend per share | 0.04 |
| Ex-div date | 21 Sep 2018 |
| Next earnings date | 6 Nov 2023 |
Downside potential
Loading...
Downside potential data
| ACET | S&P500 | |
| Current price drop from All-time high | -98.84% | -6.74% |
| Highest price drop | -98.86% | -56.47% |
| Date of highest drop | 25 Aug 2023 | 9 Mar 2009 |
| Avg drop from high | -78.47% | -11.49% |
| Avg time to new high | 157 days | 13 days |
| Max time to new high | 1395 days | 1805 days |
Get the latest news and real-time alerts from Adicet Bio, Inc. (ACET) stock at Seeking Alpha.
June 1, 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adicet Bio, Inc. (ACET) stock at Seeking Alpha.
May 9, 2023
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
72.59M
Marketcap category
Small-cap
Description
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and chimeric adaptors to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also develops ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors; and ADI-925, a novel engineered CAd gamma delta T cell product candidate targeting tumor stress ligands. Adicet Bio, Inc. is based in Boston, Massachusetts.
Employees
132
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
The following slide deck was published by Adicet Bio, Inc.
March 29, 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adicet Bio, Inc. (ACET) stock at Seeking Alpha.
March 15, 2023
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
All eyes are on Adicet Bio as a pivotal study is launched into its cell therapeutics. Read more to see why Adicet stands out from the CAR-T crowd.
February 7, 2023
Get the latest news and real-time alerts from Adicet Bio, Inc. (ACET) stock at Seeking Alpha.
December 12, 2022
Get the latest news and real-time alerts from Adicet Bio, Inc. (ACET) stock at Seeking Alpha.
December 9, 2022
Get the latest news and real-time alerts from Adicet Bio, Inc. (ACET) stock at Seeking Alpha.
November 8, 2022
Get the latest news and real-time alerts from Adicet Bio, Inc. (ACET) stock at Seeking Alpha.
October 17, 2022
The following slide deck was published by Adicet Bio, Inc.
August 12, 2022
Get the latest news and real-time alerts from Adicet Bio, Inc. (ACET) stock at Seeking Alpha.
August 10, 2022
Today, we take a look at Adicet Bio for the first time. The company is pioneering what it hopes will be among the next wave of CAR-T therapies and is advancing its lead candidate.
July 22, 2022
The following slide deck was published by Adicet Bio, Inc.
July 1, 2022
The following slide deck was published by Adicet Bio, Inc.
June 10, 2022
iO Charts is a Seeking Alpha partnerNext page